Parkinson Disease

Onapgo is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in people with advanced Parkinson disease.

Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.

The association between air pollution and Parkinson disease was found strongest in the Rocky Mountain region and the Mississippi-Ohio River Valley in a new study.

This adult beverage may actually provide health benefits, specifically for Alzheimer, Parkinson, and other neurological conditions.

Progressive weakness, confusion, and decreased oral intake preceded hospital admission for this 73-year-old man with a history of Parkinson dementia and resection for esophageal adenocarcinoma. The real problem, seen here, was revealed on a chest x-ray film.